UNSPSC 51101644: Carnidazole

This classification denotes an antiprotozoal agent with the molecular formula C8H12N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RH5KI819JG, chemically known as carbamothioic acid, (2-(2-methyl-5-nitro-1h-imidazol-1-yl)ethyl)-, o-methyl ester but generally known as carnidazole, which bears US NIH Compound Identifier 3032998. European Medicines Agency schedules Carnidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06133MIG. The term CARNIDAZOLE is an International Non-Proprietary Name.

UNSPSC 51101644 Carnidazole is a Commodity code that nominally identifies a specific antibiotic compound, but the recent state and local opportunities solicited under it do not align with carnidazole procurement. Instead, the code surfaces in solicitations for broad pharmaceutical supply categories — generic multi-source drugs, over-the-counter products, naloxone kits, and pharmacy benefit program services — indicating a tagging or classification mismatch between the code's narrow chemical scope and the actual procurement activity posted beneath it. State and local governments buying under this code are acquiring emergency medical supplies (naloxone and drug deactivation systems), first-aid consumables and respiratory equipment for fire departments, generic pharmaceuticals through cooperative purchasing, and evaluating direct-to-manufacturer prescription fulfillment models. Issuing bodies include county health departments (Seminole County, Florida), city fire and rescue services (Tampa), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Department of Administration administering MMCAP).

Recent opportunities span Florida, Texas, Minnesota, and Oregon. The City of Tampa Purchasing Department issued an IFB (26P00145) on March 25, 2026, for medical and first aid supplies to support the Tampa Fire Department Rescue Division — 169 line items including respiratory equipment, cardiac monitoring electrodes, airway devices, and consumables, estimated at $700,000.00, designated as a sheltered-market small local business enterprise (SLBE) set-aside with a 5% bid discount capped at $10,000, and responses due March 13, 2026. Seminole County, Florida solicited naloxone and drug deactivation systems (IFB 60459723LAS, posted June 30, 2026, due July 26, 2023) for quarterly delivery in quantities of 1,900 naloxone units and 800 deactivation systems annually. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with awards effective July 1, 2026. The Texas HHS Commission posted an RFI (HHS0017013) on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The mismatch between the code's narrow chemical identity and the breadth of pharmaceutical and medical-supply categories posted under it signals that this code shows little relevant recent activity aligned with carnidazole specifically.